Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kentucky for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kentucky only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kentucky (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Christopher Phillips (NPI 1912024563)

Field	Value
Entity Type	Individual
Organization	Christopher Phillips
Address	100 Kiana Court
City	Paducah
State	KY
ZIP	42001
Taxonomy	Internal Medicine Physician
NPI Enumerated	March 26, 2007

Payer Source	Total Paid
Medicare	$2.8M
Medicaid	$0

Key Findings

Provider profile and scale: CHRISTOPHER PHILLIPS is an Internal Medicine Physician in PADUCAH, KY with an NPI enumerated on 2007-03-26 (~19 years ago). Lifetime Medicare revenue on file is $2.8M and there is no Medicaid billing on file, making the provider effectively single-payer (Medicare) in the available claims data.

Revenue concentration: this provider’s Medicare income is highly concentrated in a small set of drug administration codes — the precomputed top 3 Medicare codes by revenue account for 72.8% of this provider's total Medicare revenue. The top three are J0717 ($896K, 31.1%), J0129 ($748.6K, 26.0%), and J3245 ($451K, 15.7%), which together dominate the $2.8M Medicare revenue base.

Business/service-line implication: the code mix points to an office-based infusion and injectable biologics practice rather than a panel that is driven by routine evaluation-and-management visits. High-revenue J-codes (J0717, J0129, J3245) and infusion/chemotherapy administration codes (96401, 96413, 96415, 96375) indicate the practice’s primary service line is physician-supervised drug administration for complex biologic and chemotherapy agents.

Competitive standing on top biologics: J0717 is a clear national high-volume outlier for this provider — 224K claims and $896K revenue (31.1% of total Medicare revenue), ranking #25 of 848 providers nationally (97th percentile; notably above typical national volume). J0129 also shows elevated national standing (22.7K claims, $748.6K revenue, rank #102 of 1221, 92th percentile; typical, unremarkable volume) while J3245 is closer to peer norms (4.1K claims, $451K revenue, rank #94 of 225, 56th percentile; typical, unremarkable volume).

Infusion and chemotherapy intensity: chemotherapy administration codes are unusually prominent for a general internal medicine taxonomy — 96401 appears as an extreme statistical outlier (1.2K claims, $56.3K revenue, 2.0% of Medicare revenue; rank #38 of 3868, 99th percentile; extreme outlier, far above typical national volume) and 96413 is also elevated (633 claims, $53.8K revenue, 1.9%; rank #357 of 7514, 95th percentile; notably above typical national volume). These patterns are consistent with dedicated infusion sessions being a material operational focus.

E/M volume versus drug revenue: evaluation-and-management services are present but account for a small share of revenue relative to drug administration — for example 99214 shows 726 claims and $58.8K revenue (2.0% of total) yet ranks highly versus peers (95th percentile; notably above typical national volume), indicating that although the provider sees many established-office visits, those visits generate far less revenue than the biologics and infusion codes. Routine E/M codes such as 99213 and lower-level visits are proportionally modest contributors to Medicare revenue.

Operational exposure and payer mix risk: with $2.8M in Medicare revenue and no Medicaid billing on file, the provider is effectively reliant on Medicare-covered drug and infusion payments; absence of Medicaid billing could reflect patient mix, credentialing, or billing choices and means payer diversification is limited in the available data. This concentration can have implications for contracting, reimbursement sensitivity, and downstream referral patterns given the large share of income tied to Medicare-administered biologics.

Tenure and market position: the provider has been enumerated since ~2007-03-26 (~19 years ago), which suggests established operating history in the market. Combined with high national rank on select J-codes and infusion outlier status, the provider appears to operate a sustained, specialized infusion/biologics service that differentiates it from typical internal medicine peers in national volume for these specific services.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

35 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	224,000	$1	$896K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	22,690	$30	$748.6K
J3245	Injection, tildrakizumab, 1 mg	4,100	$110	$451K
J3262	Injection, tocilizumab, 1 mg	65,520	$10	$327.6K
J1602	Injection, golimumab, 1 mg, for intravenous use	11,650	$10	$128.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	730	$80	$58.8K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	1,920	$30	$57.6K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	1,200	$50	$56.3K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	630	$90	$53.8K
J0897	Injection, denosumab, 1 mg	1,680	$20	$30.2K

Showing 1–10 of 35

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 35 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kentucky Distribution

Christopher Phillips — 8 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kentucky

Full comparison — all codes billed, vs. state median

35 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3245	5	10	4,900	$110	$616.7K
J0129	5	30	9,700	$30	$415.4K
Q5104	2	10	1,920	$30	$308.8K
J0717	3	30	46,400	$1	$288.1K
J3262	2	10	33,960	$1	$183.8K
J1602	10	20	11,560	$10	$141.6K
J0897	46	80	2,280	$20	$59.6K
96413	2	50	100	$90	$16.7K
96401	1	20	200	$50	$14.3K
99214	246	7,230	110	$70	$14.1K

Showing 1–10 of 35

Related Providers

Other providers that share a Tax Identification Number (TIN) with Christopher Phillips, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Jessica Frizzell	KY	Medical Physician Assistant	$625.9K	$0
Jacques Youssef	KY	Nephrology Physician	$322.1K	$0
Valerie Mcnamara	KY	Family Nurse Practitioner	$312.6K	$0
Jonathan Wilkerson	KY	Nephrology Physician	$286.8K	$0
Shaukat Ali	KY	Nephrology Physician	$254.9K	$0
Melissa Purvis	KY	Internal Medicine Physician	$180.8K	$0

Nearby Providers

Other providers in the same ZIP code as Christopher Phillips, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Center For Comprehensive Services, Inc	KY	Rehabilitation Hospital	$0	$47.8M
Western Ky Regional Mhmr Board Inc	KY	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$39.3M
Western Ky Regional Mhmr Board Inc	KY	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$29.1M
Easter Seals West Kentucky, Inc.	KY	Behavior Analyst	$0	$17.8M
Shelly Baer	KY	Clinical Social Worker	$105.8K	$9.8M
Emerald Therapy Center, LLC	KY	Community/Behavioral Health Agency	$0	$9.8M
Easter Seals West Kentucky	KY	Developmentally Disabled Services Day Training Agency	$0	$8.1M
Bhg Xxxiii, LLC	KY	Substance Use Disorder Rehabilitation Clinic/Center	$124.1K	$4.8M
Arcare	KY	Federally Qualified Health Center (FQHC)	$0	$4.4M
Legacy Oxygen And Home Care Equipment LLC	KY	Oxygen Equipment & Supplies (DME)	$0	$4.1M

Christopher Phillips — Billing Profile & Reimbursement Data

Sign up for Christopher Phillips — Billing Profile & Reimbursement Data policy alerts

Christopher Phillips — Billing Profile & Reimbursement Data

Sign up for Christopher Phillips — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References